On May 23, the U.S. Food and Drug Administration (FDA) announced the approval of telaprevir for the treatment of chronic viral hepatitis C. According to the U.S. Centers for Disease Control and Prevention, chronic viral hepatitis C affects 3.2 million
Read More...
Read the complete post at http://feedproxy.google.com/~r/aids/gov/~3/dQRk9ty9lQU/fda-approves-second-new-treatment-for-hepatitis-c.html
Posted
May 25 2011, 06:00 AM
by
AIDS.gov blog